Lenalidomide Plus Prednisone Results in Durable Clinical, Histopathologic, and Molecular Responses in Patients With Myelofibrosis

PURPOSE: To investigate the safety and efficacy of the combination of lenalidomide and prednisone in patients with myelofibrosis (MF). PATIENTS AND METHODS: Forty patients with MF were treated. Therapy consisted of lenalidomide 10 mg/d (5 mg/d if baseline platelet count < 100 × 10(9)/L) on days 1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Quintás-Cardama, Alfonso, Kantarjian, Hagop M., Manshouri, Taghi, Thomas, Deborah, Cortes, Jorge, Ravandi, Farhad, Garcia-Manero, Guillermo, Ferrajoli, Alessandra, Bueso-Ramos, Carlos, Verstovsek, Srdan
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879697/
https://ncbi.nlm.nih.gov/pubmed/19720904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.22.6548
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados